Stockscreener 앱 받기
29.95
4.42%
-1.38
시간 외 거래:
29.95
전일 마감가:
$31.33
열려 있는:
$30.33
하루 거래량:
413.71K
Relative Volume:
1.16
시가총액:
$1.26B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.81%
1개월 성능:
+37.61%
6개월 성능:
+151.22%
1년 성능:
+50.10%
1일 변동 폭
$29.63
$32.01
1주일 범위
$26.88
$32.01
52주 변동 폭
$5.83
$34.33
Zenas Biopharma Inc Stock (ZBIO) Company Profile
명칭
Zenas Biopharma Inc
전화
857-271-2954
주소
852 WINTER STREET, SUITE 250, WALTHAM
ZBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
29.95 | 1.48B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.77 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 개시 | Wedbush | Outperform |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Citigroup | Buy |
| 2024-10-08 | 개시 | Guggenheim | Buy |
| 2024-10-08 | 개시 | Jefferies | Buy |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Zenas Biopharma Inc 주식(ZBIO)의 최신 뉴스
Will Zenas BioPharma Inc. stock sustain high P E ratiosJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - newser.com
Will Zenas BioPharma Inc. benefit from macro trendsMarket Rally & Long-Term Safe Investment Ideas - newser.com
Is Zenas BioPharma Inc. stock a dividend growth opportunityPortfolio Return Report & Real-Time Stock Movement Alerts - newser.com
How risky is Zenas BioPharma Inc. stock nowEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
What dividend safety score for Zenas BioPharma Inc. stockJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
Price momentum metrics for Zenas BioPharma Inc. explainedWeekly Market Report & Reliable Price Breakout Signals - newser.com
How to track smart money flows in Zenas BioPharma Inc.Dollar Strength & Fast Entry High Yield Stock Tips - newser.com
Multi asset correlation models including Zenas BioPharma Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com
How to build a dashboard for Zenas BioPharma Inc. stockJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Applying chart zones and confluence areas to Zenas BioPharma Inc.July 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
How Zenas BioPharma Inc. stock reacts to inflationary pressuresMarket Growth Review & Low Risk Entry Point Tips - newser.com
Has Zenas BioPharma Inc. formed a bullish divergenceTrade Analysis Report & Weekly Momentum Picks - newser.com
Is Zenas BioPharma Inc. stock ready for breakoutQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
Leading vs lagging indicators on Zenas BioPharma Inc. performanceJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
Citigroup Raises Zenas BioPharma (NASDAQ:ZBIO) Price Target to $46.00 - MarketBeat
Zenas BioPharma, Inc.Common Stock (Nasdaq:ZBIO) Stock Quote - FinancialContent
Weiss Ratings Reiterates Sell (E+) Rating for Zenas BioPharma (NASDAQ:ZBIO) - MarketBeat
HC Wainwright Reduces Earnings Estimates for Zenas BioPharma - MarketBeat
Strategies to average down on Zenas BioPharma Inc.Insider Selling & Technical Entry and Exit Tips - newser.com
Published on: 2025-10-31 01:53:58 - newser.com
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7.3%Here's What Happened - MarketBeat
Is Zenas BioPharma Inc a good long term investmentPortfolio Allocation Tips & Free Phenomenal Trading Returns - earlytimes.in
Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN
Promising Phase 2 Results and Strategic Licensing Drive Buy Rating for Zenas BioPharma - TipRanks
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Zenas BioPharma (NASDAQ:ZBIO) Given Outperform Rating at Wedbush - MarketBeat
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
HC Wainwright & Co. Maintains Zenas BioPharma (ZBIO) Buy Recommendation - MSN
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap UpWhat's Next? - MarketBeat
1 Trial, 2 Franchises: Zenas Stock Climbs on Landmark Data - sharewise.com
ZBIO: Citigroup Raises Price Target, Maintains Buy Rating | ZBIO Stock News - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire
ZBIO: Morgan Stanley Raises Price Target, Maintains Overweight R - GuruFocus
Zenas Biopharma Inc (ZBIO) 재무 분석
Zenas Biopharma Inc (ZBIO)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Zenas Biopharma Inc 주식 (ZBIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
Oct 09 '25 |
Buy |
19.00 |
126,315 |
2,399,985 |
1,917,895 |
| ENRIGHT PATRICK G | Director |
Oct 09 '25 |
Buy |
19.00 |
105,265 |
2,000,035 |
1,832,669 |
| ENRIGHT PATRICK G | Director |
Oct 09 '25 |
Buy |
20.85 |
11,990 |
249,992 |
11,990 |
| MOULDER LEON O JR | See Remarks |
Oct 07 '25 |
Buy |
20.85 |
36,928 |
769,949 |
36,928 |
| Fairmount Funds Management LLC | Director |
Oct 07 '25 |
Buy |
19.00 |
316,219 |
6,008,161 |
2,209,025 |
| Lu Hongbo | Director |
Oct 07 '25 |
Buy |
19.00 |
263,160 |
5,000,040 |
321,983 |
| MOULDER LEON O JR | Chief Executive Officer |
Feb 18 '25 |
Buy |
6.67 |
25,000 |
166,750 |
266,155 |
| Xiao Ting | Director |
Feb 07 '25 |
Buy |
7.76 |
10,000 |
77,600 |
47,000 |
| MOULDER LEON O JR | Chief Executive Officer |
Dec 04 '24 |
Buy |
9.98 |
45,000 |
449,100 |
241,155 |
| MOULDER LEON O JR | Chief Executive Officer |
Dec 03 '24 |
Buy |
10.76 |
25,000 |
269,000 |
196,155 |
1.29%
0.56%
자본화:
|
볼륨(24시간):